Basic Information
Basic information for LINC00917-217-44aa
Peptide Name LINC00917-217-44aa
Genome Position chr16:86332158-86332289[-]
Species Human
Peptide Sequence MGVTIAITQGLLSRPRSQAGAWFLWVGRGAGHGQEEGKGTCASR
Peptide Length 44
Unique No (LINC00917-201-44aa,LINC00917-202-44aa,LINC00917-204-44aa,LINC00917-206-44aa,LINC00917-207-44aa,LINC00917-208-44aa,LINC00917-209-44aa,LINC00917-210-44aa,LINC00917-211-44aa,LINC00917-212-44aa,LINC00917-213-44aa,LINC00917-214-44aa,LINC00917-215-44aa)
Grand Average of Hydropathicity -0.2068
Relative Molecular Mass 5373.97
Experimental Evidences no
lncRNA ID/Name ENSG00000168367;LINC00917
Transcript ID/Name ENST00000670118;LINC00917-217
Transcript Length 2513
Coding Ability 0.3645
DNA Sequence Corresponding to Peptide ATGGGTGTCACCATTGCCATCACTCAAGGACTTCTCTCCAGGCCCCGAAGCCAAGCTGGTGCCTGGTTCCTCTGGGTTGGGAGAGGGGCTGGGCATGGACAGGAGGAGGGAAAAGGGACCTGTGCTAGCAGG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :